🇺🇸 Bravelle in United States

91 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 91

Most-reported reactions

1. Drug Ineffective — 54 reports (59.34%)
2. Headache — 9 reports (9.89%)
3. Nausea — 5 reports (5.49%)
4. Pain — 5 reports (5.49%)
5. Abdominal Distension — 3 reports (3.3%)
6. Abortion Spontaneous — 3 reports (3.3%)
7. Anxiety — 3 reports (3.3%)
8. Dizziness — 3 reports (3.3%)
9. Muscle Spasms — 3 reports (3.3%)
10. Ovarian Hyperstimulation Syndrome — 3 reports (3.3%)

Source database →

Frequently asked questions

Is Bravelle approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bravelle in United States?

Instituto de Investigacion Sanitaria La Fe is the originator. The local marketing authorisation holder may differ — check the official source linked above.